ENVBEnveric BiosciencesENVB info
$0.50info0.64%24h
Global rank36659
Market cap$1.17M
Change 7d-3.96%
YTD Performance-60.30%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Enveric Biosciences (ENVB) Stock Overview

    Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Its lead program is EB-373, an active metabolite of psilocybin, which is in Phase 1 clinical trials for the treatment of anxiety disorders; EVM-301 for treating mental health; and EV104 CBD + Celecoxib conjugate for treating osteoarthritis. The company also developing cannabinoid-infused topical product for the treatment of radiodermatitis; and cannabinoid and COX-2 inhibitor conjugation that is in pre-clinical stage for the treatment of OA/acute pain. Enveric Biosciences, Inc. is headquartered in Naples, Florida.

    ENVB Stock Information

    Symbol
    ENVB
    Address
    4851 Tamiami Trail NNaples, FL 34103United States
    Founded
    -
    Trading hours
    -
    Website
    https://www.enveric.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    239 302 1707

    Enveric Biosciences (ENVB) Price Chart

    -
    Value:-

    Enveric Biosciences Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.5042
    N/A
    Market Cap
    $1.17M
    N/A
    Shares Outstanding
    2.32M
    N/A
    Employees
    25.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org